Crucell NV said that Cees de Jong, its chief operating officer, has been nominated for the company’s management board with responsibility for overseeing a review of Crucell’s
News - Appointments
Shire Plc, a UK speciality biopharmaceutical company, has appointed Michael Rosenblatt, MD, as a non-executive director.
Innate Pharma SA, the French developer of cancer treatments that operate through the innate immune system, has appointed Hemanshu Shah as Executive Vice President and Chief Business Officer at
Addex Pharmaceuticals Ltd, the Swiss developer of small molecule therapeutic agents, said that Raymond Hill was elected to its board of directors at its annual general meeting on 18 April 2008.
Addex Pharmaceuticals Ltd, the Swiss developer of small molecule agents, has appointed Laurent Massuyeau as head of business development.
IP Group Plc has appointed Francis Carpenter to its board of directors as a non-executive director.
Peter Coggins has been appointed non-executive director at Asterand Plc, a provider of human tissue and other services to pharmaceutical companies doing drug discovery work.
The board of SwedenBIO has appointed Mats Berggren to be chief executive officer, succeeding Per-Erik Sandlund who has held this position since 2005.
UCB has announced that Norman J. Ornstein is a candidate to be appointed to its Board of Directors on 24 April 2008.
The European Medicines Agency has announced five appointments to its scientific working parties and one to its main scientific committee, the Committee for Medicinal Products for Human Use (CHM